Ex Parte Reexamination Surges Past IPR
The reign of Inter Partes Review (IPR) as the go-to for challenging U.S. patents is over. New data reveals a dramatic pivot toward Ex Parte Reexamination.
The reign of Inter Partes Review (IPR) as the go-to for challenging U.S. patents is over. New data reveals a dramatic pivot toward Ex Parte Reexamination.
They say you don't get a second bite at the apple. Except, apparently, if you're a patent challenger at the USPTO. This isn't strategy; it's structural rot.
Western Digital's last-second reexam filing smells like desperation—or genius gaming. USPTO's trying, but patent killers keep finding holes.
Patent challengers thought their original standing declaration would cover amended claims. Wrong. The Federal Circuit just said no, forcing fresh proof—and that's a game-changer for AI patent battles.